AI-generated summary
The authors studied 71 stem-cell transplant patients receiving melphalan, randomly assigned to oral cryotherapy plus laser therapy, laser therapy alone, or no specific treatment. The authors report that the cryotherapy plus laser group had the lowest oral mucositis scores and fewest days with mucositis, with severe grades seen only in the control group.
- Participants
- 71
- Who or what was studied
- Adults undergoing hematopoietic stem-cell transplantation with melphalan conditioning, including patients with multiple myeloma and other hematopoietic neoplasms
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not describe blinding or the group sizes' impact on certainty, and the control group was not a sham-treated group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 40 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Control group, Low-level laser therapy, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.